Investigational Site Number :2760006

Münster 48149

0 studies enrolling now · 2 studies all time

What they study most

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Multiple Sclerosis

Studies at this site

• Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis — Running, not enrolling
• Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia — Stopped early